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Despite a decreasing gender gap in exercise participation, there still remains a significant 
underrepresentation of women included in sport and exercise medicine research studies.[1] A 
review of 1382 sport and exercise research studies involving over six million participants between 
2011-2013 found the representation of women to be 39%.[1] The complexities of the menstrual 
cycle are considered major barriers to the inclusion of women in clinical trials.   
Historically, partially due to concerns of potentially damaging unborn foetuses, medical trials 
including drug trials, were conducted solely in men. Further, women were perceived as more 
physiologically variable, therefore utilising only male subjects would allow meaningful results with 
fewer participants and less funding. Because men were viewed as adequate proxies for women, 
the years of exclusion of female subjects from research were considered inconsequential.  
However, it is now known that women can respond very differently than men to drug treatments. 
Evidence suggests that women are almost twice as likely to have an adverse reaction to a drug 
than a male counterpart, and 80% of drugs withdrawn from the market are due to unacceptable 
side effects in women.[2] 
When research involving exercise metabolism includes women, participants are often tested in the 
early follicular phase of their menstrual cycle, when hormone levels are at their lowest, in order to 
minimise the possible impacts oestradiol and progesterone may have on the study outcomes.[3] 
This type of research practice leaves much ambiguity around how such hormones may influence 
the unique physiological processes in women, from blood pressure to substrate metabolism, thus 
perpetuating the significant gap in understanding how the menstrual cycle impacts exercise 
performance. Sheel (2016) recently described a number of sex differences in the physiological 
response to exercise, likely caused in part by ovarian hormones highlighting a lack of 
understanding and a need for further research.[4]  
We recently reported that 41.7% of exercising women believe there to be a negative impact of 
their menstrual cycle on exercise training and performance.[5] However, largely due to the dearth 
of sports and exercise research in women, explanations for this are lacking. Heavy menstrual 
bleeding with unknown or undiagnosed iron deficiency could be a cause but this is speculative. 
There is a clear need to gain a better understanding of female physiology and to define the effects 
of the cyclical variations in hormones, both positive and negative, upon athletic performance. A 
greater understanding of the menstrual cycle is needed to address the reported negative impacts 
on exercise training in order to encourage participation and avoid further disparity in gender 
representation. 
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